UNSPSC 51241117: Unoprostone

This classification denotes a prostaglandin analogue and anti-glaucoma agent with the molecular formula C22H38O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6X4F561V3W, chemically known as 13,14-dihydro-15-keto-20-ethyl pgf2alpha but generally known as unoprostone, which bears US NIH Compound Identifier 5311236. European Medicines Agency schedules Unoprostone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11381MIG.

UNSPSC 51241117 Unoprostone, a Commodity code, covers the procurement of unoprostone, a prostaglandin analog used primarily in ophthalmic applications for reducing intraocular pressure in glaucoma and ocular hypertension treatment. State and local governments procure unoprostone through pharmacy benefit programs, correctional health services, public health clinics, and institutional healthcare facilities including state hospitals, county jails, and municipal clinics. The medication is typically sourced through competitive pharmaceutical bidding processes, group purchasing organizations, or state Medicaid formularies. Issuing bodies soliciting under this code span state departments of health and corrections, county health departments, city public health agencies, and regional healthcare systems that maintain formulary drug lists and manage bulk pharmaceutical procurement.

The source provides no recent state and local contract opportunities under UNSPSC 51241117. Without posted solicitations, response dates, issuing-body activity patterns, or geographic concentration data, current market activity and procurement momentum under this Commodity code cannot be assessed from available records.